RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCa signaling pathway

Biology Open

Volumn 3, Issue 10, 2014, Pages 995-1004

  Maillard, Loïc ^a   Saito, Naoaki ^b   Hlawaty, Hanna ^a   Friand, Véronique ^a   Suffee, Nadine ^a   Chmilewsky, Fanny ^a   Haddad, Oualid ^a   Laguillier, Christelle ^a,c   Guyot, Erwan ^a,c   Ueyama, Takehiko ^b   Oudar, Olivier ^a   Sutton, Angela ^a,c   Charnaux, Nathalie ^a,c  

^a Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^b KOBE UNIVERSITY   (Japan)

^c HÔPITAL JEAN VERDIER   (France)

Author keywords

Chemokine; Endothelial cell; PKC; RANTES CCL5; Syndecan 4

Indexed keywords

EID: 84979242838     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20148227     Document Type: Article

References (43)

1. Bass, M. D., Roach, K. A., Morgan, M. R., Mostafavi-Pour, Z., Schoen, T., Muramatsu, T., Mayer, U., Ballestrem, C., Spatz, J. P. and Humphries, M. J. (2007). Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J. Cell Biol. 177, 527-538.
2. Bass, M. D., Morgan, M. R., Roach, K. A., Settleman, J., Goryachev, A. B. and Humphries, M. J. (2008). p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J. Cell Biol. 181, 1013-1026.
3. Beauvais, D. M. and Rapraeger, A. C. (2010). Syndecan-1 couples the insulinlike growth factor-1 receptor to inside-out integrin activation. J. Cell Sci. 123, 3796-3807.
4. Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J. and Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
5. Charni, F., Friand, V., Haddad, O., Hlawaty, H., Martin, L., Vassy, R., Oudar, O., Gattegno, L., Charnaux, N. and Sutton, A. (2009). Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim. Biophys. Acta 1790, 1314-1326.
6. Chen, F., Yu, Y., Haigh, S., Johnson, J., Lucas, R., Stepp, D. W. and Fulton, D. J. R. (2014). Regulation of NADPH oxidase 5 by protein kinase C isoforms. PLoS ONE 9, e88405.
7. Clissi, B., D'Ambrosio, D., Geginat, J., Colantonio, L., Morrot, A., Freshney, N. W., Downward, J., Sinigaglia, F. and Pardi, R. (2000). Chemokines fail to up-regulate beta 1 integrin-dependent adhesion in human Th2 T lymphocytes. J. Immunol. 164, 3292-3300.
8. Corti, F., Finetti, F., Ziche, M. and Simons, M. (2013). The syndecan-4/protein kinase Ca pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo. J. Biol. Chem. 288, 12712-12721.
9. Denhez, F., Wilcox-Adelman, S. A., Baciu, P. C., Saoncella, S., Lee, S., French, B., Neveu, W. and Goetinck, P. F. (2002). Syndesmos, a syndecan-4 cytoplasmic domain interactor, binds to the focal adhesion adaptor proteins paxillin and Hic-5. J. Biol. Chem. 277, 12270-12274.
10. Di Marzio, P., Dai, W. W., Franchin, G., Chan, A. Y., Symons, M. and Sherry, B. (2005). Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem. Biophys. Res. Commun. 331, 909-916.
11. Dovas, A., Yoneda, A. and Couchman, J. R. (2006). PKCbeta-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J. Cell Sci. 119, 2837-2846.
12. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., Detmar, M. and Goetinck, P. (2001). Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14.
13. Elfenbein, A., Rhodes, J. M., Meller, J., Schwartz, M. A., Matsuda, M. and Simons, M. (2009). Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway. J. Cell Biol. 186, 75-83.
14. Finsen, A. V., Lunde, I. G., Sjaastad, I., ∅stli, E. K., Lyngra, M., Jarstadmarken, H. O., Hasic, A., Nygård, S., Wilcox-Adelman, S. A., Goetinck, P. F. et al. (2011). Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PLoS ONE 6, e28302.
15. Gao, Y., Li, M., Chen, W. and Simons, M. (2000). Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J. Cell. Physiol. 184, 373-379.
16. Gandhi, N. S. and Mancera, R. L. (2008). The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72, 455-482.
17. Granés, F., Berndt, C., Roy, C., Mangeat, P., Reina, M. and Vilaró, S. (2003). Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain. FEBS Lett. 547, 212-216.
18. Greene, D. K., Tumova, S., Couchman, J. R. and Woods, A. (2003). Syndecan-4 associates with alpha-actinin. J. Biol. Chem. 278, 7617-7623.
19. Grootjans, J. J., Zimmermann, P., Reekmans, G., Smets, A., Degeest, G., Dürr, J. and David, G. (1997). Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. USA 94, 13683-13688.
20. Horowitz, A. and Simons, M. (1998). Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J. Biol. Chem. 273, 25548-25551.
21. Horowitz, A., Murakami, M., Gao, Y. and Simons, M. (1999). Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C. Biochemistry 38, 15871-15877.
22. Horowitz, A., Tkachenko, E. and Simons, M. (2002). Fibroblast growth factorspecific modulation of cellular response by syndecan-4. J. Cell Biol. 157, 715-725.
23. Kinnunen, T., Kaksonen, M., Saarinen, J., Kalkkinen, N., Peng, H. B. and Rauvala, H. (1998). Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273, 10702-10708.
24. Kwon, M. J., Jang, B., Yi, J. Y., Han, I. O. and Oh, E. S. (2012). Syndecans play dual roles as cell adhesion receptors and docking receptors. FEBS Lett. 586, 2207-2211.
25. Lim, S. T., Longley, R. L., Couchman, J. R. and Woods, A. (2003). Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J. Biol. Chem. 278, 13795-13802.
26. Martin, L., Blanpain, C., Garnier, P., Wittamer, V., Parmentier, M. and Vita, C. (2001). Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40, 6303-6318.
27. Masukawa, K., Sakai, N., Ohmori, S., Shirai, Y. and Saito, N. (2006). Spatiotemporal analysis of the molecular interaction between PICK1 and PKC. Acta Histochem. Cytochem. 39, 173-181.
28. Morgan, M. R., Hamidi, H., Bass, M. D., Warwood, S., Ballestrem, C. and Humphries, M. J. (2013). Syndecan-4 phosphorylation is a control point for integrin recycling. Dev. Cell 24, 472-485.
29. Multhaupt, H. A., Yoneda, A., Whiteford, J. R., Oh, E. S., Lee, W. and Couchman, J. R. (2009). Syndecan signaling: when, where and why? J. Physiol. Pharmacol. 60 Suppl. 4, 31-38.
30. Murakami, M., Horowitz, A., Tang, S., Ware, J. A. and Simons, M. (2002). Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J. Biol. Chem. 277, 20367-20371.
31. Nellen, A., Heinrichs, D., Berres, M. L., Sahin, H., Schmitz, P., Proudfoot, A. E., Trautwein, C. and Wasmuth, H. E. (2012). Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury. PLoS ONE 7, e36614.
32. Oh, E. S., Woods, A. and Couchman, J. R. (1997). Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272, 8133-8136.
33. Oh, E. S., Woods, A., Lim, S. T., Theibert, A. W. and Couchman, J. R. (1998). Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J. Biol. Chem. 273, 10624-10629.
34. Okina, E., Grossi, A., Gopal, S., Multhaupt, H. A. and Couchman, J. R. (2012). Alpha-actinin interactions with syndecan-4 are integral to fibroblast-matrix adhesion and regulate cytoskeletal architecture. Int. J. Biochem. Cell Biol. 44, 2161-2174.
35. Proudfoot, A. E., Fritchley, S., Borlat, F., Shaw, J. P., Vilbois, F., Zwahlen, C., Trkola, A., Marchant, D., Clapham, P. R. and Wells, T. N. (2001). The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276, 10620-10626.
36. Rossi, D. and Zlotnik, A. (2000). The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
37. Slimani, H., Charnaux, N., Mbemba, E., Saffar, L., Vassy, R., Vita, C. and Gattegno, L. (2003a). Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Glycobiology 13, 623-634.
38. Slimani, H., Charnaux, N., Mbemba, E., Saffar, L., Vassy, R., Vita, C. and Gattegno, L. (2003b). Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Biochim. Biophys. Acta 1617, 80-88.
39. Soria, G. and Ben-Baruch, A. (2008). The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285.
40. Suffee, N., Richard, B., Hlawaty, H., Oudar, O., Charnaux, N. and Sutton, A. (2011). Angiogenic properties of the chemokine RANTES/CCL5. Biochem. Soc. Trans. 39, 1649-1653.
41. Suffee, N., Hlawaty, H., Meddahi-Pelle, A., Maillard, L., Louedec, L., Haddad, O., Martin, L., Laguillier, C., Richard, B., Oudar, O. et al. (2012). RANTES/ CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 15, 727-744.
42. Sutton, A., Friand, V., Papy-Garcia, D., Dagouassat, M., Martin, L., Vassy, R., Haddad, O., Sainte-Catherine, O., Kraemer, M., Saffar, L. et al. (2007). Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Mol. Cancer Ther. 6, 2948-2958.
43. Tkachenko, E., Elfenbein, A., Tirziu, D. and Simons, M. (2006). Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ. Res. 98, 1398-1404.